COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020–2021

The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, per...

Descripción completa

Detalles Bibliográficos
Autores principales: Atherstone, Christine J., Guagliardo, Sarah Anne J., Hawksworth, Anthony, O’Laughlin, Kevin, Wong, Kimberly, Sloan, Michelle L., Henao, Olga, Rao, Carol Y., McElroy, Peter D., Bennett, Sarah D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461680/
https://www.ncbi.nlm.nih.gov/pubmed/37494699
http://dx.doi.org/10.3201/eid2909.230142
Descripción
Sumario:The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91–0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91–0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters.

Ejemplares similares